Compare · MOH vs YDES
MOH vs YDES
Side-by-side comparison of Molina Healthcare Inc (MOH) and YD Bio Limited (YDES): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MOH and YDES operate in Medical Specialities (Health Care), so they compete in similar markets.
- MOH is the larger of the two at $9.16B, about 23.8x YDES ($385.0M).
- Over the past year, MOH is down 45.1% and YDES is down 60.7% - MOH leads by 15.6 points.
- MOH has been more active in the news (3 items in the past 4 weeks vs 1 for YDES).
- MOH has more recent analyst coverage (25 ratings vs 0 for YDES).
- Company
- Molina Healthcare Inc
- YD Bio Limited
- Price
- $175.91+0.84%
- $5.25+4.79%
- Market cap
- $9.16B
- $385.0M
- 1M return
- +25.82%
- -33.59%
- 1Y return
- -45.10%
- -60.70%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2003
- News (4w)
- 3
- 1
- Recent ratings
- 25
- 0
Molina Healthcare Inc
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. The company operates in two segments, Health Plans and Other. As of December 31, 2020, it served approximately 4.0 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 15 states. The company offers its health care services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies. Molina Healthcare, Inc. was founded in 1980 and is headquartered in Long Beach, California.
Latest MOH
- SEC Form 10-Q filed by Molina Healthcare Inc
- Molina Healthcare Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Molina Healthcare Reports First Quarter 2026 Financial Results
- SEC Form 4 filed by Grohowski Leo P
- SEC Form 4 filed by Lockhart Stephen H
- SEC Form 4 filed by Orlando Steven J
- SEC Form 4 filed by Wolf Dale B
- SEC Form 4 filed by Zoretic Richard C
- SEC Form 4 filed by Schapiro Richard M
- SEC Form 4 filed by Brasier Barbara L
Latest YDES
- Amendment: SEC Form 3 filed by new insider Lu Shao-Ta
- SEC Form 4 filed by Lu Shao-Ta
- SEC Form 4 filed by Chang Kochi
- SEC Form 3 filed by new insider Lu Shao-Ta
- SEC Form 3 filed by new insider Chang Kochi
- YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States
- SEC Form 3 filed by new insider Lee Jerry Yin-Chia
- SEC Form 3 filed by new insider Zhang Bo-Xiang
- SEC Form 3 filed by new insider Hen Man Edmund
- SEC Form 3 filed by new insider Shen Ethan Phd